Tower Research Capital (TRC)’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-43,752
| Closed | -$58K | – | 7085 |
|
|
2022
Q1 | $58K | Sell |
43,752
-2,018
| -4% | -$2.68K | ﹤0.01% | 2620 |
|
|
2021
Q4 | $62K | Buy |
45,770
+39,925
| +683% | +$54.1K | ﹤0.01% | 2604 |
|
|
2021
Q3 | $17K | Sell |
5,845
-116
| -2% | -$337 | ﹤0.01% | 3906 |
|
|
2021
Q2 | $21K | Buy |
5,961
+1,040
| +21% | +$3.66K | ﹤0.01% | 3866 |
|
|
2021
Q1 | $17K | Sell |
4,921
-3,157
| -39% | -$10.9K | ﹤0.01% | 4033 |
|
|
2020
Q4 | $155K | Sell |
8,078
-7,150
| -47% | -$137K | ﹤0.01% | 1952 |
|
|
2020
Q3 | $205K | Buy |
15,228
+13,370
| +720% | +$180K | ﹤0.01% | 2556 |
|
|
2020
Q2 | $79K | Buy |
1,858
+438
| +31% | +$18.6K | ﹤0.01% | 2668 |
|
|
2020
Q1 | $39K | Buy |
+1,420
| New | +$39K | ﹤0.01% | 1407 |
|
|
2019
Q3 | – | Sell |
-1,703
| Closed | -$63K | – | 4713 |
|
|
2019
Q2 | $63K | Buy |
1,703
+880
| +107% | +$32.6K | ﹤0.01% | 1461 |
|
|
2019
Q1 | $18K | Sell |
823
-4,334
| -84% | -$94.8K | ﹤0.01% | 2345 |
|
|
2018
Q4 | $72K | Sell |
5,157
-131
| -2% | -$1.83K | 0.01% | 1113 |
|
|
2018
Q3 | $102K | Buy |
5,288
+3,650
| +223% | +$70.4K | 0.01% | 1336 |
|
|
2018
Q2 | $36K | Sell |
1,638
-2,375
| -59% | -$52.2K | ﹤0.01% | 2063 |
|
|
2018
Q1 | $85K | Buy |
+4,013
| New | +$85K | 0.01% | 1376 |
|